Cargando…

Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair

SIMPLE SUMMARY: DNA repair has an important role in malignant pleural mesothelioma tumorigenesis and progression. The prognosis of mesothelioma patients is very poor and predictive biomarkers are needed for better management. We analyzed the expression of more than 700 genes involved in different ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ganzinelli, Monica, Guffanti, Federica, Ianza, Anna, Sobhani, Navid, Crovella, Sergio, Zanconati, Fabrizio, Bottin, Cristina, Confalonieri, Marco, Fumagalli, Stefano, Guglielmi, Alessandra, Generali, Daniele, Damia, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486625/ https://www.ncbi.nlm.nih.gov/pubmed/37686585 http://dx.doi.org/10.3390/cancers15174309

Ejemplares similares

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2018)

Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma
por: Sobhani, Navid, et al.
Publicado: (2017)

Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma
por: D’Angelo, Alberto, et al.
Publicado: (2019)

Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
por: Sobhani, Navid, et al.
Publicado: (2018)

Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer
por: Sobhani, Navid, et al.
Publicado: (2020)

Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
por: Balduit, Andrea, et al.
Publicado: (2023)

EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
por: Ianza, Anna, et al.
Publicado: (2021)

Predictive modeling of gene expression regulation
por: Regondi, Chiara, et al.
Publicado: (2021)

Primary intrahepatic malignant epithelioid mesothelioma
por: Perysinakis, Iraklis, et al.
Publicado: (2014)

Expression of genes involved in DNA repair and cell cycle checkpoint pathways in Triple Negative compared to Luminal A Breast Cancer: a molecular characterization
por: Ganzinelli, Monica, et al.
Publicado: (2012)

Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report
por: Sobhani, Navid, et al.
Publicado: (2023)

Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer
por: Ianza, Anna, et al.
Publicado: (2021)

PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy
por: Sobhani, Navid, et al.
Publicado: (2017)

The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study
por: Roviello, Giandomenico, et al.
Publicado: (2019)

A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection
por: Bortul, Marina, et al.
Publicado: (2023)

Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts
por: Guffanti, Federica, et al.
Publicado: (2018)

Histological comparison of malignant epithelioid mesothelioma in young and adult cattle
por: KAWASHIMA, Yuuto, et al.
Publicado: (2021)

Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma
por: Ollila, Hely, et al.
Publicado: (2022)

Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma
por: Saddozai, Umair Ali Khan, et al.
Publicado: (2022)

The 5′UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs
por: Rulli, Eliana, et al.
Publicado: (2016)

Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2021)

Triple Negative Breast Cancers Have a Reduced Expression of DNA Repair Genes
por: Ribeiro, Enilze, et al.
Publicado: (2013)

C1q–HA Matrix Regulates the Local Synthesis of Hyaluronan in Malignant Pleural Mesothelioma by Modulating HAS3 Expression
por: Vidergar, Romana, et al.
Publicado: (2021)

RhoA and vigilin are candidates for immunohistochemical markers for epithelioid malignant mesothelioma
por: Hiratsuka, Takuya, et al.
Publicado: (2022)

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study
por: Ghanim, B, et al.
Publicado: (2015)

Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth
por: Agostinis, Chiara, et al.
Publicado: (2017)

Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment
por: Dal Ben, Matteo, et al.
Publicado: (2017)

The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments
por: Sobhani, Navid, et al.
Publicado: (2020)

Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts
por: Guffanti, Federica, et al.
Publicado: (2020)

Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity
por: Brcic, Luka, et al.
Publicado: (2021)

KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma
por: Vannucchi, Margherita, et al.
Publicado: (2023)

Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications
por: Tierno, Domenico, et al.
Publicado: (2023)

Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma
por: Cornelissen, Robin, et al.
Publicado: (2014)

Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC/mesothelin expression
por: Kojima, Masataka, et al.
Publicado: (2020)

Apatinib Mesylate Inhibits the Proliferation and Metastasis of Epithelioid Malignant Peritoneal Mesothelioma In Vitro and In Vivo
por: Yang, Zhi-Ran, et al.
Publicado: (2020)

Diagnostic Challenges in Epithelioid Pleural Mesothelioma: Case Series with Support from Electron Microscopy
por: Fortarezza, Francesco, et al.
Publicado: (2021)

Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach
por: Klotz, Laura V., et al.
Publicado: (2022)

Mutant p53 as an Antigen in Cancer Immunotherapy
por: Sobhani, Navid, et al.
Publicado: (2020)

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
por: Sobhani, Navid, et al.
Publicado: (2021)

p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis
por: Sobhani, Navid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0tl5va37e1l1enusc1ssnd8a9b